Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction

The New England Journal of Medicine
K DikshitH J Swan

Abstract

No abstract listed.

References

Apr 15, 1967·Lancet·R W Biagi, B N Bapat
Feb 1, 1972·The American Journal of Cardiology·W Ganz, H J Swan
Aug 1, 1968·The American Journal of Cardiology·W M Kirkendall, J H Stein
Apr 1, 1971·The American Journal of Cardiology·K E KimC Swartz
Nov 22, 1966·Annals of the New York Academy of Sciences·F C Reubi
Nov 1, 1966·Circulation·W B StasonJ H Laragh
May 1, 1970·Clinical Science·A E Tattersfield, M W McNicol
Mar 7, 1970·The Medical Journal of Australia·E Stock
Mar 1, 1971·The American Journal of Medicine·M ScheinmanE Rapaport
Jul 1, 1968·American Heart Journal·M DavidovF A Finnerty
May 31, 1969·British Medical Journal·M L BhatiaS B Roy
Dec 1, 1967·Circulation Research·A G BirtchA C Barger
May 1, 1945·The Journal of Clinical Investigation·H W SmithM Graber

❮ Previous
Next ❯

Citations

Sep 1, 1995·Clinical Cardiology·R Roberts
Jul 1, 1975·Journal of Clinical Pharmacology·J K VydenM Groseth-Dittrich
Mar 1, 1996·Journal of Clinical Pharmacology·K HaradaK Ohashi
Jul 1, 1996·Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·S A Nasraway
Jan 1, 1990·Pediatric Pulmonology·J M DavisJ V Aranda
May 1, 1994·Naunyn-Schmiedeberg's Archives of Pharmacology·B J JanssenJ F Smits
Aug 17, 1977·European Journal of Clinical Pharmacology·F Andreasen, E Mikkelsen
Feb 6, 1976·European Journal of Clinical Pharmacology·K J BergT E Wideroe
Mar 17, 1978·European Journal of Clinical Pharmacology·F AndreasenE Mikkelsen
Feb 1, 1994·Cardiovascular Drugs and Therapy·C R Swanepoel
Dec 1, 1993·Cardiovascular Drugs and Therapy·S H Taylor
Jan 1, 1993·Cardiovascular Drugs and Therapy·B Silke
Jan 1, 1980·Intensive Care Medicine·J CarletF Lemaire
Sep 1, 1986·Canadian Anaesthetists' Society Journal·P N FymanP A Casthely
Jul 1, 1988·European Journal of Drug Metabolism and Pharmacokinetics·V HeimsothO Schuster
Apr 21, 2007·Heart Failure Reviews·Steven M Hollenberg
Jan 1, 1974·The American Journal of Cardiology·P WalinskyH J Swan
Dec 1, 1979·The American Journal of Cardiology·J Figueras, M H Weil
Jan 1, 1984·General Pharmacology·A O OyekanR B Ashorobi
Mar 15, 1989·Journal of the American College of Cardiology·W W Parmley
Jan 1, 1989·Journal of the American College of Cardiology·E A Amsterdam
Oct 1, 1993·Journal of the American College of Cardiology·R J Cody
Jul 29, 2000·European Journal of Pharmacology·E KelsoP Spiers
Aug 11, 2000·European Journal of Pharmacology·F S LambS J Lewis
Apr 13, 2001·Journal of the American College of Cardiology·P S JhundJ J McMurray
Dec 1, 1987·Journal of the American College of Cardiology·R K GoldbergS Goldman
Sep 1, 1996·Journal of Critical Care·J B WaughT L Clanton
Aug 24, 2004·International Journal of Obstetric Anesthesia·S C Robson
Jan 16, 2013·Nature Reviews. Cardiology·Andrew L Clark, John G F Cleland
Nov 18, 2000·British Journal of Pharmacology·F PourageaudJ L Freslon
Jul 25, 2000·British Journal of Clinical Pharmacology·P S JhundA P Davie
Apr 12, 2000·Kidney International·R W SchrierW T Abraham
Dec 13, 1973·The New England Journal of Medicine·C CrexellsH J Swan
Mar 14, 1974·The New England Journal of Medicine·S J FunderburkJ K Vyden
Dec 16, 1976·The New England Journal of Medicine·J S ForresterH J Swan
Sep 20, 1984·The New England Journal of Medicine·P D Goldenheim, H Kazemi
Dec 26, 1991·The New England Journal of Medicine·A D BerstenC J Baggoley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.